Date: 2011-03-31
Type of information: Development agreement
Compound: malaria vaccine
Company: Cytos Biotechnology (Switzerland) United States Army (USA)
Therapeutic area: Infectious diseases - Parasitic diseases
Type agreement: development
Action mechanism:
Disease: malaria
Details: Cytos Biotechnology has entered a Cooperative Research and Development Agreement (CRADA) for the preclinical development of a malaria vaccine with the Walter Reed Army Institute of Research (WRAIR). Cytos Biotechnology will provide its virus-like particle (VLP) based vaccination technology and expertise whilst WRAIR will contribute a malaria antigen candidate. Vaccine candidates generated by Cytos Biotechnology will be tested in preclinical models of malaria disease by WRAIR.
Financial terms:
Latest news:
